A Therapeutic Strategy for Chemotherapy-Resistant Gastric Cancer via Destabilization of Both β-Catenin and RAS

Treatment of advanced gastric cancer patients with current standard chemotherapeutic agents frequently results in resistance, leading to poor overall survival. However, there has been no success in developing strategies to overcome it. We showed the expression levels of both β-catenin and RAS were s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Won-Ji, Lee, Jae Eun, Cho, Yong-Hee, Lee, Gunho, Seo, Mi-kyoung, Lee, Sang-Kyu, Hwang, Jeong-Ha, Min, Do Sik, Noh, Sung Hoon, Paik, Soonmyung, Kim, Sangwoo, Cheong, Jae-Ho, Choi, Kang-Yell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521309/
https://www.ncbi.nlm.nih.gov/pubmed/30965636
http://dx.doi.org/10.3390/cancers11040496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521309/
https://www.ncbi.nlm.nih.gov/pubmed/30965636
http://dx.doi.org/10.3390/cancers11040496

Ejemplares similares